70 Top Scientists and Industry Leaders Pinpoint Solutions to Improve Research Reproducibility at GBSI's 2016 BioPolicy Summit
Wednesday, February 17, 2016 - 14:32
in Mathematics & Economics
More than 70 leading scientists and industry leaders gathered last week in Washington, DC and via webcast to take on the problem of reproducibility in preclinical research that is a major concern in the biomedical community and continues to contribute to delays and increased costs of discoveries and development of treatments and cures. Global Biological Standard Institute (GBSI) hosted the discussion at its 2016 BioPolicy Summit--Research Reproducibility: Innovative Solutions to Drive Quality. The archived webcast is available now.